These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9736228)
1. Plasma levels of carboxy terminal propeptide of type I procollagen and pyridinoline cross-linked telopeptide of type I collagen in healthy school children. Kikuchi T; Hashimoto N; Kawasaki T; Kataoka S; Takahashi H; Uchiyama M Acta Paediatr; 1998 Aug; 87(8):825-9. PubMed ID: 9736228 [TBL] [Abstract][Full Text] [Related]
2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M; Fukunaga M; Ohtawa T; Harada T World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [TBL] [Abstract][Full Text] [Related]
3. [Serum concentration of pyridinoline cross-linked carboxy-terminal telopeptide of type-I collagen (ICTP) and carboxyterminal propeptide of human type I procollagen (PICP) in the diagnosis of bone metastases]. Koizumi M; Yamada Y; Takiguchi T; Suzuki C; Akashi T; Nomura E; Yamashita T; Ogata E Kaku Igaku; 1996 Jan; 33(1):77-84. PubMed ID: 8819718 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Kubo T; Tanaka H; Inoue M; Kanzaki S; Seino Y Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer. Akimoto S; Akakura K; Shimazaki J Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556 [TBL] [Abstract][Full Text] [Related]
6. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels]. Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinoma. Hosoya Y; Arai K; Honda M; Sumi S; Yoshida K Eur Urol; 1997; 31(2):220-3. PubMed ID: 9076470 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices. Murakami T; Kusachi S; Murakami M; Sano I; Uesugi T; Hirami R; Kajiyama A; Kondo J; Tsuji T Clin Chem; 1998 Dec; 44(12):2453-61. PubMed ID: 9836712 [TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer. Tähtelä R; Thölix E Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558 [TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone (GH) replacement on plasma carboxy-terminal propeptide of type I procollagen (PICP) and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) levels in GH-deficient adult patients. Murakami Y; Sugitani M; Koshimura K; Sohmiya M; Kato Y Endocr J; 1998 Apr; 45 Suppl():S121-4. PubMed ID: 9790245 [No Abstract] [Full Text] [Related]
11. Dynamics of bone turnover in children with GH deficiency treated with GH until final height. Baroncelli GI; Bertelloni S; Ceccarelli C; Cupelli D; Saggese G Eur J Endocrinol; 2000 Jun; 142(6):549-56. PubMed ID: 10822216 [TBL] [Abstract][Full Text] [Related]
12. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia]. Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894 [TBL] [Abstract][Full Text] [Related]
13. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma. Ueno T; Hashimoto O; Sugawara H; Ogata R; Kusaba N; Torimura T; Sata M; Tanikawa K Int J Oncol; 1998 Aug; 13(2):297-303. PubMed ID: 9664125 [TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP]. Kobayashi Y; Ochi M; Tokue A Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802 [TBL] [Abstract][Full Text] [Related]
15. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy. Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245 [TBL] [Abstract][Full Text] [Related]
16. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Elomaa I; Virkkunen P; Risteli L; Risteli J Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907 [TBL] [Abstract][Full Text] [Related]
17. Type I collagen and procollagen fragments in patients with metabolic bone diseases. Lin JS; Kao JT; Tsai KS J Formos Med Assoc; 1996 Jul; 95(7):523-9. PubMed ID: 8840753 [TBL] [Abstract][Full Text] [Related]
18. Annual serum PICP and ICTP and antler growth in female reindeer (Rangifer tarandus tarandus). Vierimaa H; Sassi ML; Eloranta E; Rahiala M; Timisjärvi J; Saarela S; Risteli J Comp Biochem Physiol B Biochem Mol Biol; 1999 Jan; 122(1):111-7. PubMed ID: 10327601 [TBL] [Abstract][Full Text] [Related]
19. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis. Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996 [TBL] [Abstract][Full Text] [Related]
20. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]